Radiosensitization of PC3 Prostate Cancer Cells by 5-Thiocyanato-2'-deoxyuridine.
Magdalena ZdrowowiczMagdalena DattaMichał RychłowskiJanusz RakPublished in: Cancers (2022)
Our findings indicate that SCNdU treatment enhances the radiosensitivity of prostate cancer cells in a manner associated with the cell cycle regulation, double strand formation, and a slight induction of apoptosis.